Available languages:
(Part 2) High-level Interactive Dialogue on Antimicrobial Resistance (AMR) - General Assembly, 75th session
29 Apr 2021 -  Panel 3: Tackling AMR at country level
Panel 4: Ensuring sufficient and sustainable AMR financing
Closing Segment

Antimicrobial Resistance (AMR) occurs when bacteria, viruses, fungi and parasites change over time as a result of drug resistance, antibiotics and other antimicrobial medicines become ineffective and infections become increasingly difficult or impossible to treat- increasing the risk of disease spread, severe illness and death.

The COVID-19 pandemic has shown the ease with which infections can spread, threaten global health security and destabilize economies, lives and livelihoods. AMR is a rising pandemic and challenges the effective delivery of the Sustainable Development Goals (SDGs).

In recent years, there has been good progress on tackling AMR but there is an urgent need to scale up action in all relevant sectors as we build back from COVID-19 and build a sustainable future for people, animals and the planet.

The General Assembly High-Level Interactive Dialogue on Tackling AMR is an important opportunity to strengthen political commitment, take stock of progress, recommit to actions, and build back better from COVID-19 by agreeing further practical steps that can effectively address challenges to tackling AMR as part of future pandemic preparedness through a One Health approach while supporting the delivery of the SDGs.

Recent Video On Demand